Concepedia

Qianxi Yang

QY

Statistics

Publications

6

Citations

353

H-Index

6

Active since

2018

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Hammersmith Hospital

Imperial College London

Qianxi Yang is an author at Tianjin Medical University Cancer Institute and Hospital specializing in oncology, molecular oncology, and medicine.

Publications per year

2018–2021

6

Publications

6

Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling

Qianxi Yang, Shaorong Zhao, Zhendong Shi et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 160 citations · Full text

Medicine, Cancer Biology, Oncology +17

Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer

Yunhui Hu, Ernesto Yagüe, Jing Zhao et al. · Cancer Letters · 2018 · 82 citations · Full text

Medicine, Oncology, Pharmacology +17

Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin–proteasomal degradation of COX-2

Teng Pan, Dongdong Zhou, Zhendong Shi et al. · Cancer Letters · 2019 · 39 citations

Medicine, Molecular Biology, Oncology +15

Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer

Lixia Cao, Shaorong Zhao, Qianxi Yang et al. · Frontiers in Oncology · 2021 · 25 citations · Full text

Medicine, Oncology, Pharmacology +15

GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation

Jingjing Liu, Lei Liu, Ernesto Yagüe et al. · Breast Cancer Research and Treatment · 2018 · 24 citations

Life Sciences, Cancer Biology, Oncology +11

1–5 of 6